Zepbound is the newest GLP-1 medication on the block. While all of these medications share a similar mechanism of action, they may differ in their specific uses, such as whether they’re more ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

How GLP-1 medications help with weight loss Who can ... Johnson is passionate about the care of overweight and obesity in all ages, especially adolescents, young adults, and Black women.

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

All participants had received stroke care at hospitals within multiple health systems in Minnesota or Wisconsin. Researchers assessed outcomes for people who were prescribed either a GLP-1 or an SGLT2 ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against ... process with no greater ...

If you had come across the abbreviation GLP-1 a few years ago, chances are you’d have had no idea what it stood for. Intro to Greek lyric poetry? Low-level Great Lakes precipitation? A member of the ...

all of whom were obese. A total of 4,052 of these kids were taking an injected GLP-1 weight loss medication such as Wegovy or Saxenda (liraglutide), while the other 50,112 were not. Of the two ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...